Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TYGACIL 50 MG

TIGECYCLINE : 50 MG · DIN 02285401 · PFIZER CANADA ULC

Health Canada status: MARKETED

What is TYGACIL?

TYGACIL 50 MG contains TIGECYCLINE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02285401, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 17-Apr-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is TYGACIL used for?

TYGACIL (tigecycline) is indicated for the treatment of complicated skin and skin structure infections (cSSSI), complicated intraabdominal infections (cIAI), and community acquired pneumonia (CAP) (mild to moderate infections only) when caused by susceptible strains of designated microorganisms in patients 18 years of age and older. TYGACIL should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria to reduce the development of drug-resistant bacteria.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02285401
Brand nameTYGACIL
Generic / active ingredientTIGECYCLINE : 50 MG
ManufacturerPFIZER CANADA ULC
Strength50 MG
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeJ01AA12 TIGECYCLINE
BiosimilarNo
Health Canada statusMARKETED
Status date17-Apr-2012
Original market date2006-09-19 00:00:00

How is it stored and handled?

Once reconstituted, TYGACIL may be stored at room temperature (not to exceed 25 °C/ 77 °F) for up to 24 hours (up to 6 hours in the vial and the remaining time in the IV bag). Alternatively, TYGACIL mixed with 0.9% Sodium Chloride Injection, USP, or 5% Dextrose Injection USP may be stored refrigerated at 2 ° to 8 °C (36 ° to 46 °F) for up to 48 hours following immediate transfer of the reconstituted solution into the IV bag.

How is it supplied?

10 vials/box

What can be used instead?

Other Canadian products sharing ATC code J01AA12 TIGECYCLINE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
TIGECYCLINE50 MGPOWDER FOR SOLUTIONAPOTEX INCMARKETEDDIN 02409356
TIGECYCLINE FOR INJECTION50 MGPOWDER FOR SOLUTIONPHARMARIS CANADA INCAPPROVEDDIN 02484749

Who else supplies TIGECYCLINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. TIGECYCLINE appears in 33 registered pack listings across 8 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TYGACIL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for TYGACIL

Health Canada Drug Product Database (DPD), DIN 02285401. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.